3.9 Article

Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation

Journal

MOLECULAR ENDOCRINOLOGY
Volume 30, Issue 10, Pages 1070-1080

Publisher

ENDOCRINE SOC
DOI: 10.1210/me.2016-1105

Keywords

-

Funding

  1. Daiichi Sankyo Co., Ltd., Medicinal Safety Research Laboratories, Japan
  2. Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation, Japan Society for the Promotion of Science (JSPS)
  3. National Institutes of Health Intramural Research Program [Z01ES1005-01]

Ask authors/readers for more resources

Comparison of 11 human nuclear receptor amino acid sequences revealed a conserved phosphorylation motif within their DNA-binding domains as an intramolecular signal that regulates proteolytic degradation. Nuclear receptors use this signal to either degrade or proscribe degradation through either the proteasome or nonproteasome pathways. A phosphomimetic farnesoid X receptor (FXR) S154D mutant neither bound to nor trans-activated an FXR-response element-driven reporter gene and was rapidly degraded in COS-1 cells. Ectopically expressed FXR had increased Ser154 phosphorylation in COS-1 cells after ligand treatment, and knock-down of the nuclear vaccinia-related kinase 1 (VRK1) greatly reduced this phosphorylation. FXR was phosphorylated at Ser154 in the nucleus of centrilobular hepatocytes only in ligand-treated mice. Thus, FXR Ser154 phosphorylation is a rheostat for activation and subsequent degradation that controls receptor levels and activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available